Alliance A221805: Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase II Study.
- DOI
- 10.1200/oa-25-00107
- Published
- 2026 Jan
- Container
- JCO oncology advances
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1200/oa-25-00107,
title = {Alliance A221805: Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase II Study.},
author = {Lavoie Smith EM and Lee M and Scott MR and Liu H and Hillman S and Rieken T and Wills R and Diaz-Cobo J and Chow S and Finnes HD and Ruddy K and Meyerhardt J and O'Reilly E and Baghdadi TA and Florez N and Kharofa J and Govindarajan R and Tejani M and Chung K and Zahrieh D and Loprinzi C and Lustberg M},
year = {2026},
journal = {JCO oncology advances},
doi = {10.1200/oa-25-00107},
url = {https://doi.org/10.1200/oa-25-00107}
}RIS
TY - JOUR TI - Alliance A221805: Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase II Study. AU - Lavoie Smith EM AU - Lee M AU - Scott MR AU - Liu H AU - Hillman S AU - Rieken T AU - Wills R AU - Diaz-Cobo J AU - Chow S AU - Finnes HD AU - Ruddy K AU - Meyerhardt J AU - O'Reilly E AU - Baghdadi TA AU - Florez N AU - Kharofa J AU - Govindarajan R AU - Tejani M AU - Chung K AU - Zahrieh D AU - Loprinzi C AU - Lustberg M PY - 2026 JO - JCO oncology advances DO - 10.1200/oa-25-00107 UR - https://doi.org/10.1200/oa-25-00107 ER -
APA
EM, L. S., M, L., MR, S., H, L., S, H., T, R., R, W., J, D., S, C., HD, F., K, R., J, M., E, O., TA, B., N, F., J, K., R, G., M, T., K, C., D, Z., C, L., & M, L. (2026). Alliance A221805: Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase II Study.. JCO oncology advances. https://doi.org/10.1200/oa-25-00107
Source records
- pubmed · retrieved 2026-09-27T09:54:28.092Z